Smith & Nephew (SNN) EBIT Growth (1y) (2010 - 2024)
Smith & Nephew (SNN) EBIT Growth (1y) (2010 - 2024) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | -20.56% |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 11.83% |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 30.43% |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 19.54% |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 20.97% |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 90.95% |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 74.18% |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | -18.12% |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Steris | 20.59 Bn | 20.16 Bn | 697.10 Mn | 46.60% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 19.27% |
| Dec 31, 2023 | 13.64% |
| Dec 31, 2022 | 1.26% |
| Dec 31, 2021 | 4,880.00% |
| Dec 31, 2020 | -101.19% |
| Dec 31, 2019 | 12.63% |
| Dec 31, 2018 | -10.14% |
| Dec 31, 2017 | 15.97% |
| Dec 31, 2016 | -18.68% |
| Dec 31, 2015 | 20.94% |
| Dec 31, 2014 | 75.36% |
| Mar 31, 2014 | -3.83% |
| Dec 31, 2013 | -2.82% |
| Mar 31, 2013 | 10.33% |
| Dec 31, 2012 | -75.29% |
| Jun 30, 2012 | -49.02% |
| Mar 31, 2012 | 111,518,324,607,229.86% |
| Dec 31, 2011 | 359,166,296.67% |
| Sep 30, 2011 | -321.84% |
| Jun 30, 2011 | 2.24% |